articleAnnals of Internal MedicineJul 16, 2020GREEN OA

Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19

University of Minnesota · McGill University Health Centre · +4 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Background

No effective oral therapy exists for early coronavirus disease 2019 (COVID-19).

Objective

To investigate whether hydroxychloroquine could reduce COVID-19 severity in adult outpatients.

Citation impact

548
total citations
FWCI
13.05
Percentile
100%
References
22
Citations per year

Authors

24

Topics & keywords

Keywords
  • Hydroxychloroquine
  • Medicine
  • Placebo
  • Clinical endpoint
  • Internal medicine
  • Adverse effect
  • Severity of illness
  • Randomized controlled trial
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding